Trader Books $13M Profit on “Nvidia of Crypto”

A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips.

Click here to review my research and the strategy I've developed for the opportunity to trade this c

PRME Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 24.29%

Insider Buying (Last 12 Months): $20,000,000.00

Insider Selling (Last 12 Months): $0.00

Prime Medicine Insider Trading History Chart

Prime Medicine Share Price & Price History

^$4.09

▲ +0.09 (2.25%)

As of 09/11/2024 01:00 AM ET

Days: 30 | 90 | 365

Preferred Stock Offer: Get an 8% dividend yield opportunity on this robotics stock

From Deal Maker | Ad

This company, known for its autonomous robotic surgical systems, completed a crowd-funded public offering and NASDAQ Listing last year. What’s next? They just filed for FDA approval to market and commercialize their patented AI joint replacement tech. By the year 2027, 50% of knee replacement surgeries will be robotic – up from 12% today.

Learn more on their website while the opportunity lasts

Prime Medicine Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/15/2024	Robert Nelsen	Director	Buy	3,200,000	$6.25	$20,000,000.00	3,200,000
6/20/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	37,405	$15.06	$563,319.30
6/16/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	6,532	$15.02	$98,110.64
6/14/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	28,960	$14.87	$430,635.20
6/12/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	16,031	$14.98	$240,144.38
6/9/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	15,672	$14.48	$226,930.56
6/5/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	22,434	$16.70	$374,647.80
5/31/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	16,633	$13.65	$227,040.45
5/26/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	12,602	$13.70	$172,647.40
5/24/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	7,900	$13.66	$107,914.00
5/22/2023	2019 Gp L.L.C. Gv	Major Shareholder	Sell	87,922	$14.13	$1,242,337.86

Natural is heading to the Nasdaq

From MedX | Ad

Natural solutions are already better for the environment. But there’s one company taking it a step further: Their natural pesticides outperform chemical alternatives. That’s already led to 200% revenue growth, thanks to e-commerce partnerships with companies like Walmart, Amazon, and Kroger.

See how you can become a shareholder while they’re still private.

SEC Filings (Institutional Ownership Changes) for Prime Medicine (NYSE:PRME)

70.37% of Prime Medicine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Prime Medicine Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	Susquehanna Portfolio Strategies LLC	29,247	$0.15M	0.0%	-75.0%	0.024%
8/15/2024	Susquehanna Fundamental Investments LLC	49,379	$0.25M	0.0%	+133.2%	0.041%
8/15/2024	The Manufacturers Life Insurance Company	24,138	$0.12M	0.0%	-67.8%	0.020%
8/15/2024	Millennium Management LLC	1,330,927	$6.84M	0.0%	+205.7%	1.109%
8/15/2024	Deerfield Management Company L.P. Series C	896,960	$4.61M	0.1%	+1.3%	0.747%
8/15/2024	AQR Capital Management LLC	34,268	$0.18M	0.0%	N/A	0.029%
8/14/2024	Squarepoint Ops LLC	63,461	$0.33M	0.0%	+6.5%	0.053%
8/14/2024	ProShare Advisors LLC	12,707	$65K	0.0%	-16.8%	0.011%
8/13/2024	Ensign Peak Advisors Inc	103,190	$0.53M	0.0%	-31.2%	0.086%
8/13/2024	Westwood Holdings Group Inc.	358,580	$1.84M	0.0%	+125.0%	0.299%
8/13/2024	Benjamin F. Edwards & Company Inc.	25,326	$0.13M	0.0%	+5,831.1%	0.021%
8/9/2024	Greenwich Wealth Management LLC	653,001	$3.36M	0.2%	+13.0%	0.544%
8/3/2024	National Bank of Canada FI	6,200	$34K	0.0%	N/A	0.005%
8/3/2024	TD Asset Management Inc	46,434	$0.24M	0.0%	-64.0%	0.039%
8/1/2024	Rhumbline Advisers	70,107	$0.36M	0.0%	+33.5%	0.058%
7/29/2024	Principal Financial Group Inc.	12,187	$63K	0.0%	-30.9%	0.010%
7/29/2024	IQ EQ FUND MANAGEMENT IRELAND Ltd	18,914	$97K	0.0%	N/A	0.016%
7/26/2024	ARK Investment Management LLC	6,126,773	$31.49M	0.3%	+2.2%	5.104%
7/26/2024	Bank of New York Mellon Corp	170,563	$0.88M	0.0%	+61.0%	0.142%
7/20/2024	Nisa Investment Advisors LLC	7,736	$40K	0.0%	+22,652.9%	0.006%
7/19/2024	Sumitomo Mitsui Trust Holdings Inc.	3,238,385	$16.65M	0.0%	-3.8%	2.698%
7/16/2024	ORG Partners LLC	5,270	$29K	0.0%	N/A	0.004%
6/6/2024	Westwood Holdings Group Inc.	159,351	$1.12M	0.0%	N/A	0.133%
5/24/2024	Farallon Capital Management LLC	750,000	$5.25M	0.0%	N/A	0.625%
5/16/2024	California State Teachers Retirement System	3,978	$28K	0.0%	-38.9%	0.003%
5/16/2024	Levin Capital Strategies L.P.	26,500	$0.19M	0.0%	+32.5%	0.022%
5/16/2024	Redmile Group LLC	2,074,350	$14.52M	0.5%	+56.6%	1.728%
5/15/2024	Price T Rowe Associates Inc. MD	2,522,590	$17.66M	0.0%	+13.6%	2.102%
5/15/2024	PEAK6 Investments LLC	17,000	$0.12M	0.0%	-22.7%	0.014%
5/14/2024	Westwood Holdings Group Inc.	159,351	$1.12M	0.0%	N/A	0.133%
5/14/2024	EntryPoint Capital LLC	7,997	$56K	0.1%	-77.3%	0.007%
5/10/2024	Vanguard Group Inc.	5,801,445	$40.61M	0.0%	+43.1%	4.833%
5/8/2024	ProShare Advisors LLC	15,276	$0.11M	0.0%	+19.8%	0.013%
5/7/2024	Susquehanna Fundamental Investments LLC	21,175	$0.15M	0.0%	N/A	0.018%
5/3/2024	Nikko Asset Management Americas Inc.	3,364,663	$23.52M	0.2%	-4.4%	2.803%
4/29/2024	China Universal Asset Management Co. Ltd.	22,378	$0.16M	0.0%	+98.8%	0.019%
4/19/2024	Sumitomo Mitsui Trust Holdings Inc.	3,364,663	$23.55M	0.0%	-4.4%	2.805%
4/15/2024	TrueMark Investments LLC	85,183	$0.60M	0.5%	+13.5%	0.071%
4/10/2024	Green Alpha Advisors LLC	33,738	$0.24M	0.2%	+14.2%	0.028%
2/21/2024	Chelsea Counsel Co.	5,000	$44K	0.0%	+733.3%	0.005%
2/14/2024	Vestal Point Capital LP	20,306	$0.18M	0.0%	N/A	0.021%
2/13/2024	Bollard Group LLC	361,136	$3.20M	0.1%	N/A	0.371%
2/9/2024	Trexquant Investment LP	26,983	$0.24M	0.0%	N/A	0.028%
2/8/2024	Nikko Asset Management Americas Inc.	3,519,029	$31.18M	0.3%	-3.2%	3.616%
2/6/2024	Vestmark Advisory Solutions Inc.	144,288	$1.28M	0.1%	N/A	0.148%
2/6/2024	Levin Capital Strategies L.P.	20,000	$0.18M	0.0%	N/A	0.021%
2/1/2024	New York State Common Retirement Fund	8,440	$75K	0.0%	-48.3%	0.009%
2/1/2024	Greenwich Wealth Management LLC	513,001	$4.55M	0.4%	+16.9%	0.527%
1/30/2024	Strs Ohio	17,100	$0.15M	0.0%	N/A	0.018%
1/30/2024	Sumitomo Mitsui Trust Holdings Inc.	3,519,029	$31.18M	0.0%	-3.2%	3.616%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	21,301	$0.19M	0.0%	-7.5%	0.022%
1/24/2024	China Universal Asset Management Co. Ltd.	11,258	$100K	0.0%	N/A	0.012%
1/17/2024	ARK Investment Management LLC	3,138,270	$27.81M	0.2%	+19.7%	3.225%
1/12/2024	SG Americas Securities LLC	10,128	$90K	0.0%	N/A	0.010%
1/11/2024	TrueMark Investments LLC	75,030	$0.67M	0.7%	N/A	0.077%
1/5/2024	Green Alpha Advisors LLC	29,538	$0.26M	0.2%	-21.9%	0.030%
12/18/2023	Vanguard Group Inc.	3,951,793	$37.70M	0.0%	+18.5%	4.060%
12/6/2023	Citigroup Inc.	56,193	$0.54M	0.0%	+296.8%	0.058%
11/14/2023	Profund Advisors LLC	21,995	$0.21M	0.0%	N/A	0.023%
11/13/2023	FMR LLC	3,922,416	$37.42M	0.0%	-2.9%	4.030%
11/13/2023	Rafferty Asset Management LLC	128,876	$1.23M	0.0%	N/A	0.132%
11/9/2023	Citigroup Inc.	56,193	$0.54M	0.0%	+296.8%	0.058%
11/8/2023	Oppenheimer & Co. Inc.	21,537	$0.21M	0.0%	+40.0%	0.022%
11/7/2023	Barclays PLC	65,140	$0.62M	0.0%	+726.8%	0.067%
11/7/2023	Greenwich Wealth Management LLC	439,021	$4.19M	0.4%	+111.1%	0.451%
10/30/2023	Sumitomo Mitsui Trust Holdings Inc.	3,634,848	$34.68M	0.0%	+18.6%	3.736%
10/27/2023	Allspring Global Investments Holdings LLC	3,067	$29K	0.0%	-73.2%	0.003%
10/27/2023	TD Asset Management Inc	104,542	$1M	0.0%	+55.9%	0.107%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	23,016	$0.22M	0.0%	+22.0%	0.024%
10/24/2023	Bank of New York Mellon Corp	115,389	$1.10M	0.0%	+11.8%	0.119%
10/18/2023	ARK Investment Management LLC	2,622,429	$25.02M	0.2%	+7.1%	2.695%
10/10/2023	Green Alpha Advisors LLC	37,815	$0.36M	0.3%	+205.3%	0.039%
9/21/2023	Barclays PLC	7,879	$0.12M	0.0%	+47.7%	0.008%
8/14/2023	Casdin Capital LLC	367,175	$5.38M	0.5%	-50.0%	0.377%
8/11/2023	Penserra Capital Management LLC	8,107	$0.12M	0.0%	+15.8%	0.008%
8/10/2023	Metropolitan Life Insurance Co NY	2,203	$32K	0.0%	+206.8%	0.002%
8/9/2023	TD Asset Management Inc	67,071	$0.98M	0.0%	+180.4%	0.069%
8/7/2023	Principal Financial Group Inc.	18,029	$0.26M	0.0%	N/A	0.019%
8/7/2023	Brown Brothers Harriman & Co.	10,065	$0.15M	0.0%	N/A	0.010%
8/4/2023	American International Group Inc.	19,040	$0.28M	0.0%	+274.3%	0.020%
8/4/2023	Alphabet Inc.	11,862,498	$173.79M	9.3%	-10.7%	12.200%
7/31/2023	Levin Capital Strategies L.P.	20,000	$0.29M	0.0%	N/A	0.021%
7/31/2023	Greenwich Wealth Management LLC	208,000	$3.05M	0.3%	-40.4%	0.214%
7/31/2023	Sumitomo Mitsui Trust Holdings Inc.	3,063,751	$44.88M	0.0%	+207.1%	3.151%
7/24/2023	Allspring Global Investments Holdings LLC	11,441	$0.17M	0.0%	+894.0%	0.012%
7/18/2023	Allspring Global Investments Holdings LLC	11,441	$0.17M	0.0%	+894.0%	0.012%
7/10/2023	ARK Investment Management LLC	2,449,199	$35.88M	0.2%	+27.4%	2.519%
7/6/2023	Green Alpha Advisors LLC	12,386	$0.18M	0.1%	N/A	0.013%

Data available starting January 2016

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address the spectrum of diseases by deploying gene editing technology. The company offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime Editor to a specific genomic location and provides a template for making the desired edit to the target DNA sequence. It has a research collaboration with Cimeio Therapeutics to develop Prime Edited Shielded-Cell & Immunotherapy Pairs for genetic diseases, acute myeloid leukemia, and myelodysplastic syndrome. The company was incorporated in 2019 and is based in Cambridge, Massachusetts.

Today's Range

Now: $4.09

$3.84

$4.10

50 Day Range

MA: $4.82

$3.55

$6.70

52 Week Range

Now: $4.09

$3.47

$13.27

Volume

714,158 shs

Average Volume

751,614 shs

Market Capitalization

$490.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.18

Who are the company insiders with the largest holdings of Prime Medicine?: Prime Medicine's top insider shareholders include:
Robert Nelsen (Director)
2019 Gp LLC Gv (Major Shareholder)
Learn More about top insider investors at Prime Medicine.
Who are the major institutional investors of Prime Medicine?: Prime Medicine's top institutional shareholders include:
ARK Investment Management LLC — 5.10%
Sumitomo Mitsui Trust Holdings Inc. — 2.70%
Millennium Management LLC — 1.11%
Deerfield Management Company L.P. Series C — 0.75%
Greenwich Wealth Management LLC — 0.54%
Westwood Holdings Group Inc. — 0.30%
Learn More about top institutional investors of Prime Medicine stock.
Which major investors are selling Prime Medicine stock?: Within the previous quarter, PRME stock was sold by these institutional investors:
Sumitomo Mitsui Trust Holdings Inc.
Susquehanna Portfolio Strategies LLC
TD Asset Management Inc
The Manufacturers Life Insurance Company
Ensign Peak Advisors Inc
Principal Financial Group Inc.
ProShare Advisors LLC
Which major investors are buying Prime Medicine stock?: Within the previous quarter, PRME stock was bought by institutional investors including:
Millennium Management LLC
Westwood Holdings Group Inc.
ARK Investment Management LLC
Greenwich Wealth Management LLC
Bank of New York Mellon Corp
AQR Capital Management LLC
Susquehanna Fundamental Investments LLC
Benjamin F. Edwards & Company Inc.